INCYTE CORPORATION Other Noncash Income (Expense)
INCYTE CORPORATION (INCY) reported Other Noncash Income (Expense) of -$12.77 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-04-28
- INCYTE CORPORATION other noncash income (expense) for the quarter ending 2026-03-31 was -$12.77M.
- INCYTE CORPORATION other noncash income (expense) for the quarter ending 2025-12-31 was -$11.41M, a 369.85% decline year-over-year.
- INCYTE CORPORATION other noncash income (expense) for the quarter ending 2025-09-30 was -$6.67M, a 189.92% decline year-over-year.
- INCYTE CORPORATION other noncash income (expense) for the quarter ending 2025-06-30 was $8.51M, a 2225.68% increase year-over-year.
- INCYTE CORPORATION other noncash income (expense) for fiscal 2025 was -$14.86M, a 264.11% decline from fiscal 2024.
- INCYTE CORPORATION other noncash income (expense) for fiscal 2024 was $9.05M.
- INCYTE CORPORATION other noncash income (expense) for fiscal 2023 was -$16.95M.
- INCYTE CORPORATION other noncash income (expense) for fiscal 2022 was -$17.37M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$12.77M 10-Q · filed 2026-04-28 | -$24.18M derived: sum of 2 quarters · filed 2026-04-28 | -$30.85M derived: sum of 3 quarters · filed 2026-04-28 | -$22.34M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-12-31 | -$11.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$18.08M derived: sum of 2 quarters · filed 2026-02-10 | -$9.56M derived: sum of 3 quarters · filed 2026-02-10 | -$14.86M 10-K · filed 2026-02-10 | ||||
| 2025-09-30 | -$6.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.85M derived: sum of 2 quarters · filed 2025-10-28 | -$3.44M 10-Q · filed 2025-10-28 | $784.00K derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-06-30 | $8.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $3.22M 10-Q · filed 2025-07-29 | $7.45M derived: sum of 3 quarters · filed 2026-04-28 | $14.86M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-03-31 | -$5.29M 10-Q · filed 2026-04-28 | -$1.06M derived: sum of 2 quarters · filed 2026-04-28 | $6.35M derived: sum of 3 quarters · filed 2026-04-28 | $6.71M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $4.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $11.64M derived: sum of 2 quarters · filed 2026-02-10 | $12.01M derived: sum of 3 quarters · filed 2026-02-10 | $9.05M 10-K · filed 2026-02-10 | ||||
| 2024-09-30 | $7.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $7.78M derived: sum of 2 quarters · filed 2025-10-28 | $4.82M 10-Q · filed 2025-10-28 | -$12.67M derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-06-30 | $366.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$2.59M 10-Q · filed 2025-07-29 | -$20.08M derived: sum of 3 quarters · filed 2026-02-10 | -$23.21M derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-03-31 | -$2.95M 10-Q · filed 2025-04-29 | -$20.45M derived: sum of 2 quarters · filed 2026-02-10 | -$23.57M derived: sum of 3 quarters · filed 2026-02-10 | -$22.55M derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2023-12-31 | -$17.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$20.62M derived: sum of 2 quarters · filed 2026-02-10 | -$19.60M derived: sum of 3 quarters · filed 2026-02-10 | -$16.95M 10-K · filed 2026-02-10 | -$22.58M 10-K · filed 2024-02-13 | |||
| 2023-09-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$2.11M derived: sum of 2 quarters · filed 2024-10-29 | $543.00K 10-Q · filed 2024-10-29 | -$1.73M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $3.67M 10-Q · filed 2024-07-30 | $1.40M derived: sum of 3 quarters · filed 2025-02-10 | -$5.23M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-03-31 | $2.65M 10-Q · filed 2024-04-30 | $382.00K derived: sum of 2 quarters · filed 2025-02-10 | -$6.25M derived: sum of 3 quarters · filed 2025-02-10 | -$12.62M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2022-12-31 | -$2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | -$8.90M derived: sum of 2 quarters · filed 2025-02-10 | -$15.28M derived: sum of 3 quarters · filed 2025-02-10 | -$17.37M 10-K · filed 2025-02-10 | ||||
| 2022-09-30 | -$6.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | -$13.01M derived: sum of 2 quarters · filed 2023-10-31 | -$15.10M 10-Q · filed 2023-10-31 | -$11.25M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-06-30 | -$6.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$8.47M 10-Q · filed 2023-08-01 | -$4.62M derived: sum of 3 quarters · filed 2024-02-13 | -$6.67M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-03-31 | -$2.09M 10-Q · filed 2023-05-02 | $1.76M derived: sum of 2 quarters · filed 2024-02-13 | -$294.00K derived: sum of 3 quarters · filed 2024-02-13 | $1.11M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2021-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $1.80M derived: sum of 2 quarters · filed 2024-02-13 | $3.21M derived: sum of 3 quarters · filed 2024-02-13 | -$1.42M 10-K · filed 2024-02-13 | ||||
| 2021-09-30 | -$2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$646.00K derived: sum of 2 quarters · filed 2022-11-01 | -$5.27M 10-Q · filed 2022-11-01 | $2.88M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$3.21M 10-Q · filed 2022-08-02 | $4.94M derived: sum of 3 quarters · filed 2023-02-07 | $4.81M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-03-31 | -$4.62M 10-Q · filed 2022-05-03 | $3.53M derived: sum of 2 quarters · filed 2023-02-07 | $3.40M derived: sum of 3 quarters · filed 2023-02-07 | -$5.02M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2020-12-31 | $8.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $8.02M derived: sum of 2 quarters · filed 2023-02-07 | -$401.00K derived: sum of 3 quarters · filed 2023-02-07 | -$546.00K 10-K · filed 2023-02-07 | ||||
| 2020-09-30 | -$131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$8.55M derived: sum of 2 quarters · filed 2021-11-02 | -$8.70M 10-Q · filed 2021-11-02 | -$8.83M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-06-30 | -$8.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$8.57M 10-Q · filed 2021-08-03 | -$8.70M derived: sum of 3 quarters · filed 2022-02-08 | -$8.83M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-03-31 | -$145.00K 10-Q · filed 2021-05-04 | -$275.00K derived: sum of 2 quarters · filed 2022-02-08 | -$404.00K derived: sum of 3 quarters · filed 2022-02-08 | -$527.00K derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2019-12-31 | -$130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | -$259.00K derived: sum of 2 quarters · filed 2022-02-08 | -$382.00K derived: sum of 3 quarters · filed 2022-02-08 | -$486.00K 10-K · filed 2022-02-08 | ||||
| 2019-09-30 | -$129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$252.00K derived: sum of 2 quarters · filed 2020-11-05 | -$356.00K 10-Q · filed 2020-11-05 | -$442.00K derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | -$123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$227.00K 10-Q · filed 2020-08-04 | -$313.00K derived: sum of 3 quarters · filed 2021-02-09 | -$399.00K derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-03-31 | -$104.00K 10-Q · filed 2020-05-05 | -$190.00K derived: sum of 2 quarters · filed 2021-02-09 | -$276.00K derived: sum of 3 quarters · filed 2021-02-09 | -$361.00K derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2018-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$172.00K derived: sum of 2 quarters · filed 2021-02-09 | -$257.00K derived: sum of 3 quarters · filed 2021-02-09 | -$344.00K 10-K · filed 2021-02-09 | ||||
| 2018-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$171.00K derived: sum of 2 quarters · filed 2019-10-29 | -$258.00K 10-Q · filed 2019-10-29 | -$332.00K derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | -$85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$172.00K 10-Q · filed 2019-07-30 | -$246.00K derived: sum of 3 quarters · filed 2020-02-13 | -$316.00K derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | -$87.00K 10-Q · filed 2019-04-30 | -$161.00K derived: sum of 2 quarters · filed 2020-02-13 | -$231.00K derived: sum of 3 quarters · filed 2020-02-13 | -$306.00K derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$144.00K derived: sum of 2 quarters · filed 2020-02-13 | -$219.00K derived: sum of 3 quarters · filed 2020-02-13 | -$290.00K 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$145.00K derived: sum of 2 quarters · filed 2018-10-30 | -$216.00K 10-Q · filed 2018-10-30 | -$363.00K derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-06-30 | -$75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$146.00K 10-Q · filed 2018-07-31 | -$293.00K derived: sum of 3 quarters · filed 2019-02-14 | -$367.00K derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-03-31 | -$71.00K 10-Q · filed 2018-05-01 | $71.00K 10-Q · filed 2017-05-04 | -$218.00K derived: sum of 2 quarters · filed 2019-02-14 | -$292.00K derived: sum of 3 quarters · filed 2019-02-14 | -$721.00K derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2016-12-31 | -$147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | -$221.00K derived: sum of 2 quarters · filed 2019-02-14 | -$650.00K derived: sum of 3 quarters · filed 2019-02-14 | -$472.00K 10-K · filed 2019-02-14 | $472.00K 10-K · filed 2017-02-14 | |||
| 2016-09-30 | -$74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$503.00K derived: sum of 2 quarters · filed 2017-10-31 | -$325.00K 10-Q · filed 2017-10-31 | $325.00K 10-Q · filed 2016-11-01 | $3.12M derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2016-06-30 | -$429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$251.00K 10-Q · filed 2017-08-01 | $251.00K 10-Q · filed 2016-08-09 | $3.19M derived: sum of 3 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $178.00K 10-Q · filed 2017-05-04 | $3.62M derived: sum of 2 quarters · filed 2018-02-15 | ||||||
| 2015-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $1.61M 10-K · filed 2018-02-15 | -$1.61M 10-K · filed 2016-02-12 | |||||
| 2015-09-30 | -$1.83M 10-Q · filed 2016-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |